KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 42 | -62.5% | 0.00% | – |
Q1 2022 | $2,000 | -88.2% | 112 | -88.8% | 0.00% | -100.0% |
Q3 2021 | $17,000 | -63.0% | 1,000 | -44.4% | 0.00% | -60.0% |
Q1 2021 | $46,000 | +206.7% | 1,800 | +44.0% | 0.01% | +66.7% |
Q3 2019 | $15,000 | +200.0% | 1,250 | +316.7% | 0.01% | +200.0% |
Q4 2018 | $5,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |